Abstract:Type of funding sources: Public grant(s) – National budget only. Main funding source(s): DFG project no. 288034826—International Research Training Group (IRTG) 2251 Gestational diabetes mellitus (GDM) is linked to an elevated risk of developing cardiovascular diseases (CVD) both for the mother and the baby in later life. Previous studies have identified fatty acid-binding protein 4 (FABP4) as a prime candidate involved in the pathophysiology of GDM. FABP4 is known to promote an inflammatory response and vascular permeability, induce oxidative stress in endothelial cells (ECs), and impair the nitric oxide signaling pathway, thereby promoting endothelial dysfunction. Indeed, women with GDM exhibit elevated blood levels of FABP4, suggesting its potential as a biomarker for endothelial dysfunction and cardiovascular risk assessment in GDM. However, the role that FABP4 plays in the fetal endothelial function remains poorly understood. Thus, our aim is to understand the role of FABP4 in fetal endothelial dysfunction and its regulation to mitigate the impact of GDM on the vasculature. Fetoplacental vessels and primary human umbilical vein endothelial cells (HUVECs) were isolated from placentas and umbilical cords obtained from both normoglycemic (NG) and GDM pregnancies. We also obtained the clinical data from the mothers and collected the cord blood. Total mRNA from HUVECs was used for bulk RNA sequencing to compare gene expression, while gene expression analysis in the vessels was conducted using RT-qPCR. Additionally, NG HUVECs were pooled and cultured under high laminar flow conditions (30 dyn/cm2) or subjected to various treatments, including insulin (5nM), glucose (25mM), simvastatin (10nm), or VEGF-A stimulation. Subsequent RT-qPCRs were performed to analyze the gene expression of several genes of interest. The bulk RNA sequencing data analysis revealed FABP4 as an overexpressed gene in GDM HUVECs compared to NG. Furthermore, the analysis of data through Gene Set Enrichment Analysis provided a list of different gene sets that are enriched in GDM samples. Among these gene sets are pathways or processes implicated in endothelial dysfunction, such as angiogenesis, PI3K/AKT/mTOR signaling, reactive oxygen species pathway, or inflammatory response. In vitro experiments provided evidence for an elevated FABP4 mRNA expression after VEGF treatment of HUVECs. Conversely, both simvastatin treatment and exposure to laminar flow reduced FABP4 mRNA expression and increased eNOS expression, suggesting a potential inhibitory effect of nitric oxide on FABP4. We provided evidence that FABP4 could be involved in fetal GDM-induced endothelial dysfunction. Shear stress and statins might protect the endothelium against the negative impact of FABP4.

Effect of FABP4 on placental trophoblastic immune inflammatory response in patients of hypertensive disorder complicating pregnancy

Increased Expression of Fatty Acid Binding Protein 4 in Preeclamptic Placenta and Its Relevance to Preeclampsia.

The correlation analysis between abnormal lipid metabolism and FABP4 expression in placenta tissue of rats with hypertension of pregnancy

Effect of FABP4 DNA methylation on abnormal lipid metabolism in trophocyte treated with L-NAME

Modulation of Fabp4 Hypomethylation by Dnmt1 and Its Inverse Interaction with Mir-148a/152 in the Placenta of Preeclamptic Rats and Htr-8 Cells

Fatty Acid-Binding Protein 4 in Endometrial Epithelium is Involved in Embryonic Implantation.

Alterations in Serum Adipocyte Fatty Acid Binding Protein and Retinol Binding Protein-4 in Normal Pregnancy and Preeclampsia.

The Effect of Trophoblasts on T Lymphocytes: Possible Regulatory Effector Molecules - A Proteomic Analysis

FABP4 as potential indicator for GDM-induced fetal endothelial dysfunction

Activation of TLR3 inhibits angiogenic factors expression in the human trophoblast cells

Expression and Function of Fatty Acid-Binding Protein 4 in Epithelial Cell of Uterine Endometrium.

Relationship Between Expression of Vimentin, Type IV Collagen and Fibronectin in Human Placenta and Pregnancy Induced Hypertension

Expression of Placental Vascular Growth Factor in Pregnancy-Induced Hypertension

[Expression of Fas and FasL in Serum and Placenta of Preeclamptic Pregnancy and Its Significance].

Multifaced Roles in Reproduction, Pregnancy, and Offspring Health

Study On The Correlation Between Adipocyte Fatty-Acid Binding Protein, Glucolipid Metabolism, And Pre-Eclampsia

The Relationship Between Inflammatory Factor Expression and Blood Pressure and Urinary Protein in the Placenta of Gestational Hypertension Rats.

Changes of platelet activating factor to hypertensive disorder complicating pregnancy

Study on the Correlation of Adipocyte Fatty-Acid Binding Protein and Gestational Diabetes Mellitus

The Expression of PLF in Placenta in Pregnancy-Induced Hypertension and the Relationship Between the PLF and Serum VCAM-1

Study on the correlation between expression level of A-FABP and insulin-resistance in the patients with preeclampsia